Up to recently, it was not possible for academic researchers to visualise the spatial distribution of intratumoural heterogeneity within solid tumours. An international research team has now reported a way to track changes with whole-tissue biospy phenotyping.
Neurim tables Phase III data of insomnia drug
Latest NewsGerman-Israeli Neurim Pharmaceuticals announced top line efficacy results of its insomnia drug PedPRM in children with autism spectrum disorders (ASD).
Erytech Pharma set to raise US$100m in IPO and private placement
Latest NewsFrench cancer drug encapsulation specialist Erytech Pharma SA wants to raise US$100m (€85m) in an IPO at NASDAQ and a subsequent private placement outside Northern America to finance pivotal trials of eryaspase in ALL and pancreatic cancer.
uniQure’s AMT-130 receives FDA Orphan Drug Designation in Huntington’s disease
Latest NewsAs first gene therapy ever, AMT-130 has been granted FDA Orphan Drug status in Huntington’s Disease.
Advanced system for touch-free membrane transfer
ProductsMicrosart ® @media Advanced System for Touch-free Membrane Transfer.
Promethera Biosciences partners with Shibuya Corp
Latest NewsPromethera Biosciences and Shibuya collaborate to establish a breakthrough cell therapy manufacturing platform.
Immatics raises $58m
Latest NewsCancer immunotherapy specialist Immatics Biotechnologies GmbH (Tuebingen, Germany) raised US$58m in a Series E financing round led by German investors dievini Hopp BioTech Holding and AT Impf as well as Wellington Partners and new investor Amgen.
Avillion names new Chief Business Officer
AppointmentsLate-stage pharmaceuticals financing and co-development specialist Avillion LLP has named Kathryn J. Gregory Chief Business Officer.
NuCana raises US$114m in IPO of ADSs
Latest NewsScotch cancer corp NuCana plc was up 3% (to US$18.61) after closing an initial public offering on Friday led by Citigroup, Jefferies and Cowen and co-managed by William Blair.
Researchers unravel patterns of cancer heterogeneity
Latest NewsUp to recently, it was not possible for academic researchers to visualise the spatial distribution of intratumoural heterogeneity within solid tumours. An international research team has now reported a way to track changes with whole-tissue biospy phenotyping.
Talents: HR Flash
OpinionThe European Biotech market is extremely dynamic, acknowledged as being number two in the world of market rankings. This is a cause for celebration!